UBS strategist Joni Teves is breaking her own rules — so are strategists at Goldman Sachs.
UBS analyst Matthew Weston maintained a Buy rating on Merck KGaA (0O14 – Research Report) today and set a price target of €190.00. The ...
Expectations of a banner year in dealmaking have not yet materialized due to worries about inflation and uncertainties over U ...
Symbotic (NASDAQ:SYM – Get Free Report) had its price target dropped by analysts at UBS Group from $32.00 to $30.00 in a research report issued to clients and investors on Tuesday,Benzinga reports.
New banking rules for UBS could face a long delay after Switzerland's finance ministry on Wednesday said it wanted lawmakers ...
Goldman Sachs Group Inc. said it’s more than 80% of the way to meeting its 2030 goal of putting $750 billion toward ...
Sempra (SRE) rebounds after a steep drop, as Goldman Sachs and UBS downgrade shares citing reduced guidance, uncertainty in growth, and regulatory risks.
Goldman Sachs analyst Andrew Baker maintained a Hold rating on Swiss Re AG (SSREF – Research Report) today and set a price target of CHF139.00.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results